---
figid: PMC5702246__12967_2017_1342_Fig6_HTML
figlink: /pmc/articles/PMC5702246/figure/Fig6/
number: F6
caption: A model of the PTHLH/PTH1R-ATF2 negative-feedback loop. PTHLH/PTH1R signaling
  activated the expression and transcriptional activity of ATF2 via the ERK1/2 and
  JNK signaling pathways to promoted ICC cell growth, and ATF2 positively regulated
  CyclinD1 expression and negatively regulated PTHLH expression. Treatment with ERK1/2
  and JNK signaling pathway inhibitors abolished ATF2 transcriptional activity
pmcid: PMC5702246
papertitle: Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma
  cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
reftext: Jing Tang, et al. J Transl Med. 2017;15:238.
pmc_ranked_result_index: '38005'
pathway_score: 0.958734
filename: 12967_2017_1342_Fig6_HTML.jpg
figtitle: The PTHLH/PTH1R-ATF2 negative-feedback loop
year: '2017'
organisms: Homo sapiens
ndex: aa779fe3-ded8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5702246__12967_2017_1342_Fig6_HTML.html
  '@type': Dataset
  description: A model of the PTHLH/PTH1R-ATF2 negative-feedback loop. PTHLH/PTH1R
    signaling activated the expression and transcriptional activity of ATF2 via the
    ERK1/2 and JNK signaling pathways to promoted ICC cell growth, and ATF2 positively
    regulated CyclinD1 expression and negatively regulated PTHLH expression. Treatment
    with ERK1/2 and JNK signaling pathway inhibitors abolished ATF2 transcriptional
    activity
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JUN
  - MAP2K1
  - MAP2K2
  - PTHLH
  - ATF2
  - RAF1
  - KRAS
  - ARAF
  - UNK
  - BRAF
  - NRAS
  - HRAS
  - U0126
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: C-Jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PTHLH
  symbol: PTHLH
  source: hgnc_symbol
  hgnc_symbol: PTHLH
  entrez: '5744'
- word: ATF-2
  symbol: ATF2
  source: hgnc_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: c-Jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: UNK
  symbol: UNK
  source: hgnc_symbol
  hgnc_symbol: UNK
  entrez: '85451'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
chemicals:
- word: U0126
  source: MESH
  identifier: C113580
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5702246__F6
redirect_from: /figures/PMC5702246__F6
figtype: Figure
---
